drugset / Trial / NCT00236275
PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
Phase 3
Completed
60 enrolled
Assistance Publique - Hôpitaux de Paris
Pierre and Marie Curie University · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
Predict and follow thanks to imaging the response to neoadjuvant chemotherapy in locally advanced breast carcinoma. Hypothesis : FLT-(18F)PET will be a predictor superior to both FDG-(18F) PET and MRI
Timeline
- Start
- 2004-05
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoro-L-thymidine-(18F) | Unknown | — | — |